[Federal Register Volume 72, Number 221 (Friday, November 16, 2007)]
[Notices]
[Page 64673]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-22473]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 26, 2007, and published in the Federal 
Register on July 5, 2007, (72 FR 36728), Amri Rensselaer, Inc., 33 
Riverside Avenue, Rensselaer, New York 12144, made application by 
letter to the Drug Enforcement Administration (DEA) to be registered as 
a bulk manufacturer of Lisdexamfetamine (1205), a basic class of 
controlled substance listed in schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for sales to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Amri Rensselaer, Inc. to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Amri Rensselaer, Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic class of controlled substance listed.

    Dated: November 5, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-22473 Filed 11-15-07; 8:45 am]
BILLING CODE 4410-09-P